surpass 6 tirzepatide Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the clinical trial programme - Bergman - 2025 - Diabetes, Obesity and Metabolism PDF] Early-Onset Type 2 Diabetes
Pay in 4 interest-free payments of $7.19 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
![surpass 6 tirzepatide Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the clinical trial programme - Bergman - 2025 - Diabetes, Obesity and Metabolism PDF] Early-Onset Type 2 Diabetes](https://figures.semanticscholar.org/47f2cbae01360a57626762aec4a9f115ff7b6417/6-Figure1-1.png)
![surpass 6 tirzepatide Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the clinical trial programme - Bergman - 2025 - Diabetes, Obesity and Metabolism PDF] Early-Onset Type 2 Diabetes](https://mms.businesswire.com/media/20231003113775/en/1905467/22/EASD_2023_Image.jpg)
![surpass 6 tirzepatide Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the clinical trial programme - Bergman - 2025 - Diabetes, Obesity and Metabolism PDF] Early-Onset Type 2 Diabetes](https://ars.els-cdn.com/content/image/1-s2.0-S2666634026001868-ga1.jpg)
![surpass 6 tirzepatide Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the clinical trial programme - Bergman - 2025 - Diabetes, Obesity and Metabolism PDF] Early-Onset Type 2 Diabetes](https://www.frontiersin.org/files/Articles/1453825/xml-images/fphar-15-1453825-g004.webp)




















